Boguslaw Okopien
Overview
Explore the profile of Boguslaw Okopien including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
439
Citations
1988
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Banach M, Surma S, Dzida G, Jozwiak J, Okopien B, Rysz J, et al.
Arch Med Sci
. 2025 Feb;
20(6):1754-1769.
PMID: 39967951
Cardiovascular diseases (CVD) prevention does not only mean effective fight against the existing and well-recognized cardiovascular risk factors, but also against their complications, including micro- and macrovascular complications. Only then...
2.
Krysiak R, Basiak M, Szkrobka W, Okopien B
Metabolites
. 2025 Jan;
15(1).
PMID: 39852352
Untreated hyperprolactinemia and autoimmune thyroiditis (Hashimoto's disease) seem to increase cardiometabolic risk. The cardiometabolic effects of cabergoline were less significant in young women with concurrent euthyroid Hashimoto's illness. This study...
3.
Krysiak R, Kowalcze K, Szkrobka W, Okopien B
Biomolecules
. 2024 Oct;
14(10).
PMID: 39456268
Low prolactin levels in men predispose them to mood disturbances, sexual dysfunction, and diabetes. The purpose of the current study was to assess cardiometabolic risk in males with hypoprolactinemia. This...
4.
Buldak L, Boldys A, Skudrzyk E, Machnik G, Okopien B
Metabolites
. 2024 Oct;
14(10).
PMID: 39452935
: Obesity is one of the major healthcare challenges. It affects one in eight people around the world and leads to several comorbidities, including type 2 diabetes, hyperlipidemia, and arterial...
5.
Krysiak R, Kowalcze K, Okopien B
J Clin Pharmacol
. 2024 Oct;
65(3):318-327.
PMID: 39363530
Metformin treatment decreases elevated concentrations of anterior pituitary hormones. The aim of this prospective, cohort study was to investigate whether hyperthyroidism modulates the impact of metformin on gonadotroph secretory function....
6.
Boldys A, Buldak L, Skudrzyk E, Machnik G, Okopien B
Endokrynol Pol
. 2024 Sep;
75(4):419-427.
PMID: 39279311
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a healthcare issue of growing concern. Its development is multifactorial, and it is more commonly seen in obese patients. In those circumstances,...
7.
Krysiak R, Kowalcze K, Szkrobka W, Okopien B
Pharmaceutics
. 2024 Aug;
16(8).
PMID: 39204438
Metformin inhibits enhanced secretion of anterior pituitary hormones. Its impact on prolactin and gonadotropin concentrations is absent in individuals with hypovitaminosis D. The aim of this prospective cohort study was...
8.
Krysiak R, Basiak M, Szkrobka W, Okopien B
Pharmaceuticals (Basel)
. 2024 Aug;
17(8).
PMID: 39204081
Metformin inhibits the secretory function of overactive anterior pituitary cells, including lactotropes. In women of childbearing age, this effect was absent if they had coexisting autoimmune (Hashimoto) thyroiditis. The current...
9.
Nicze M, Dec A, Borowka M, Krzyzak D, Boldys A, Buldak L, et al.
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125772
Obesity is a chronic disease caused primarily by the imbalance between the amount of calories supplied to the body and energy expenditure. Not only does it deteriorate the quality of...
10.
Surma S, Zembala M, Okopien B, Banach M
Int J Cardiol Cardiovasc Risk Prev
. 2024 Jul;
22:200297.
PMID: 38962113
Lipoprotein(a) is a recognized risk factor for ASCVD. There is still no targeted therapy for Lp(a), however, drugs such as pelacarsen, olpasiran, zerlasiran, lepodisiran and muvalaplin are in clinical trials...